Rui Tato Marinho
Rui Tato Marinho
Medical School of Lisbon, University of Lisbon, Hospital S. Maria
Email confirmado em sapo.pt
TítuloCitado porAno
ABT-450/r–ombitasvir and dasabuvir with or without ribavirin for HCV
P Ferenci, D Bernstein, J Lalezari, D Cohen, Y Luo, C Cooper, E Tam, ...
New England Journal of Medicine 370 (21), 1983-1992, 2014
8272014
Retreatment of HCV with ABT-450/r–ombitasvir and dasabuvir with ribavirin
S Zeuzem, IM Jacobson, T Baykal, RT Marinho, F Poordad, M Bourlière, ...
New England Journal of Medicine 370 (17), 1604-1614, 2014
6752014
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The Lancet Gastroenterology & Hepatology 2 (3), 161-176, 2017
5052017
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
M Cornberg, HA Razavi, A Alberti, E Bernasconi, M Buti, C Cooper, ...
Liver International 31, 30-60, 2011
4942011
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ...
Journal of viral hepatitis 21, 34-59, 2014
4012014
Historical epidemiology of hepatitis C virus (HCV) in selected countries
P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ...
Journal of viral hepatitis 21, 5-33, 2014
2872014
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients
RN Gunson, D Shouval, M Roggendorf, H Zaaijer, H Nicholas, ...
Journal of Clinical Virology 27 (3), 213-230, 2003
2182003
Strategies to manage hepatitis C virus (HCV) disease burden
H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ...
Journal of viral hepatitis 21, 60-89, 2014
2092014
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
1172018
Efficacy of glecaprevir/pibrentasvir for 8 or 12 weeks in patients with hepatitis C virus genotype 2, 4, 5, or 6 infection without cirrhosis
T Asselah, KV Kowdley, N Zadeikis, S Wang, T Hassanein, Y Horsmans, ...
Clinical Gastroenterology and Hepatology 16 (3), 417-426, 2018
1152018
Hepatitis C, stigma and cure
RT Marinho, DP Barreira
World Journal of Gastroenterology: WJG 19 (40), 6703, 2013
892013
Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe
AD Marshall, EB Cunningham, S Nielsen, A Aghemo, H Alho, ...
The Lancet Gastroenterology & Hepatology 3 (2), 125-133, 2018
792018
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ...
The Lancet Gastroenterology & Hepatology 2 (5), 325-336, 2017
792017
Treatment and prognostic factors in patients with hepatocellular carcinoma
A Martins, H Cortez‐Pinto, P Marques‐Vidal, N Mendes, S Silva, N Fatela, ...
Liver International 26 (6), 680-687, 2006
642006
Intermediate hepatocellular carcinoma: current treatments and future perspectives
JF Dufour, I Bargellini, N De Maria, P De Simone, I Goulis, RT Marinho
Annals of oncology 24 (suppl_2), ii24-ii29, 2013
622013
Data mining framework for fatty liver disease classification in ultrasound: a hybrid feature extraction paradigm
UR Acharya, SV Sree, R Ribeiro, G Krishnamurthi, RT Marinho, ...
Medical physics 39 (7Part1), 4255-4264, 2012
612012
Automated stratification of liver disease in ultrasound: An online accurate feature classification paradigm
L Saba, N Dey, AS Ashour, S Samanta, SS Nath, S Chakraborty, ...
Computer methods and programs in biomedicine 130, 118-134, 2016
592016
Three decades of hepatitis B control with vaccination
LC Meireles, RT Marinho, P Van Damme
World journal of hepatology 7 (18), 2127, 2015
512015
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: an integrated analysis of HCV genotype 1–6 patients without cirrhosis
M Puoti, GR Foster, S Wang, D Mutimer, E Gane, C Moreno, TT Chang, ...
Journal of hepatology 69 (2), 293-300, 2018
502018
Eradication of hepatitis C virus reduces the risk of hepatocellular carcinoma in patients with compensated cirrhosis
J Velosa, F Serejo, R Marinho, J Nunes, H Glória
Digestive diseases and sciences 56 (6), 1853-1861, 2011
482011
O sistema não pode efectuar a operação agora. Tente novamente mais tarde.
Artigos 1–20